Combination antibody kit for risk assessment of postoperative recurrence of primary hepatocellular carcinoma
A technology for hepatocellular carcinoma and a kit, applied in the biological field, can solve problems such as low efficacy, and achieve the effects of simple detection process, mature experimental method, and objective and accurate results.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0026] A combined antibody kit for risk assessment of postoperative recurrence of primary hepatocellular carcinoma, which includes 8 protein molecules detected by primary antibodies: CD80, B7-DC, HLA-DR, FasL, Bcl-2 , CK19, Ki-67 and Cyclin D1, clear positive signals can be detected in paraffin sections of liver cancer tissues by using 8 kinds of primary antibodies (such as figure 1 shown), the specific steps include the following three parts:
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com